Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Subsequently, we performed protein immunoblotting and semi-quantitative analysis, which revealed that, compared to the control group, the degradation rate of GFP-VSR2 was significantly increased in protoplasts transformed with RNAi vectors targeting SNX1 or SNX2 (Fig
They are not approved for human use by the FDA outside of clinical trials
Identity fields include CAS 2381089-83-2
In 2023, Di Lorenzo et al
In a 12-month clinical trial involving 404 HIV-infected patients with excess abdominal fat, Tesamorelin (2 mg daily) significantly reduced visceral adipose tissue (VAT) compared to placebo
US$ 23.07
US$ 28.65
US$ 20.15
US$ 23.45
